Improving Breast Cancer Hormone Receptor Testing in Tanzania A Study on Diagnosis Challenges and Support Systems

What this Trial Is About

Researchers are studying the challenges and support related to breast cancer diagnosis in Tanzania. This observational study focuses on understanding barriers to hormone receptor testing in breast cancer patients and the healthcare system. The goal is to improve the diagnosis process by gathering insights from survivors, patient advocates, and key healthcare personnel. The study involves behavioral interventions such as semi-structured focus group discussions and the use of a survey tool called Organizational Readiness for Implementing Change ORIC. The focus groups explore contextual factors, barriers, and facilitators to implementing changes, while the ORIC tool assesses how prepared organizations are for change using participant ratings on a 5-point scale. Participants include breast cancer survivors, patient advocates, and healthcare workers involved in breast cancer care. Participants will engage in focus groups and complete readiness assessments. Data collection involves interviews and chart reviews to identify diagnosis barriers over one year. The research team evaluates organizational preparedness and collects participant feedback through discussions. The study is expected to continue until April 2027, with no direct treatment involved, focusing on improving breast cancer diagnosis support and processes.

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania